X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Featured

Germany Rolls First CAR-T Push For Muscle Inflammation Cure

Content Team by Content Team
27th February 2023
in Featured, News, Research & Development

One of the university hospitals in Germany was the first in the world to effectively treat a patient with a severe case of muscular inflammation (myositis) using chimeric antigen receptor CAR-T cells.

The danger of acquiring an extremely severe form of an autoimmune inflammatory illness is significant, according to the researchers. The patient who underwent the CAR-T treatment was identified as having the anti-synthetase syndrome. The disease, according to the paper’s authors, arises when the immune system mistakenly attacks aminoacyl-tRNA synthetases, enzymes needed for the synthesis of amino acids.

CAR-T Cell Therapy For Muscular Inflammation

Professor Andreas Mackensen from Hematology and Oncology described CAR-T cells as immune cells that have been taken out of the patient’s blood and genetically altered to carry a CAR. Once the cells have been reintroduced to the patient’s body, the CAR enables the altered immune cells to target only the disease-causing cells.

Own immune cells from the patients were altered by the researchers. The patient’s health significantly improved following the CAR-T cell infusion, the researchers reported. The patient’s strength and stamina returned, and the muscle inflammation in their joints and lungs nearly completely subsided.

Professor Dr. Georg Schett, Director of the Department of Medicine 3 for Rheumatology and Immunology, stated that autoimmune inflammatory muscle illnesses may end catastrophically if they are discovered either at a later stage or patients fail to react appropriately to medicines intended to suppress the immune system.

Dr. Fabian Muller emphasized that the patient stopped taking all immune-suppressive medications without experiencing a flare-up of the illness. The patient had made a recovery from the disease six months after getting the CAR-T cells, according to the researchers.

The German Research Foundation’s Joint Research Centers 1181 and 221 as well as the Free State of Bavaria’s High-Tech Agenda and the 4I Immunocluster Erlangen-Regensburg-Wurzburg have all contributed funding to the research conducted by professors Schett and Mackensen.

This is the second autoimmune condition that medical professionals and researchers at one of the university’s hospitals have successfully treated with CAR-T cell treatment. The first instance was when the cells were successful in treating systemic lupus erythematosus (SLE).

As part of the clinical Castle research, which will begin this year, additional patients with myositis or SLE will have the chance to benefit from CAR-T cell therapy.

Previous Post

More Monitoring Required of Institutional Review Boards

Next Post

Hong Kong Gives $500mn Funding For Chinese Drug Development

Related Posts

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Drugs Gain From Tardigrade Proteins, Says Research
Drug Development

Pharma Drugs Gain From Tardigrade Proteins, Says Research

22nd March 2023
Next Post

Hong Kong Gives $500mn Funding For Chinese Drug Development

Latest News

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In